02/14/2025
3:43 PM | L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Sunshine Biopharma (Subject)
Sunshine Biopharma Inc. (Subject)
| Form SCHEDULE 13G/A | |
01/21/2025
7:20 AM | Roy Michel (Reporting)
Sunshine Biopharma (Issuer)
Sunshine Biopharma Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/15/2025
11:15 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form EFFECT | |
01/15/2025
7:30 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
10:44 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/10/2024
3:26 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:28 PM | ARMISTICE CAPITAL, LLC (Filed by)
Sunshine Biopharma (Subject)
Sunshine Biopharma Inc. (Subject)
| Form SC 13G/A | |
11/12/2024
10:29 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 424B4 | |
11/07/2024
3:40 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
12:43 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form POS AM | |
11/05/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:00 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/20/2024
2:34 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
9:40 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form NT 10-Q | |
05/06/2024
11:14 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
1:26 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:05 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/15/2024
10:14 AM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form DEF 14C | |
03/01/2024
3:19 PM | Sunshine Biopharma (Filer)
Sunshine Biopharma, Inc (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
